Niva Bupa Health Insurance Company Limited IPO

Apply 0
Avoid 0

The mission is to empower every Indian with the confidence to access top-tier healthcare through their range of comprehensive health insurance products and services. This mission is realized by providing customers with an integrated health ecosystem that supports them throughout their healthcare journey. They are recognized as one of India’s largest and fastest-growing Standalone Health Insurers (SAHI), achieving an overall health Gross Direct Premium Income (GDPI) of ₹54,944.28 million in Fiscal 2024.

Product Innovation and Customer-Centric Approach

Over their 16 years of operations, they have continually evolved their offerings to meet the dynamic needs of their customers. This focus on innovation has helped them build a diverse product portfolio that appeals to a wide range of customer demographics. Their flagship platform, the ‘Niva Bupa Health’ mobile app and website, provides customers access to a holistic health ecosystem that includes diagnostics, digital consultations, annual health check-ups, and educational content. Through this digital platform, users can also manage claims, service their policies, and monitor health metrics, enhancing their overall experience.

Strategic Promoters and Global Expertise

Their promoters, Bupa Singapore Holdings Pte. Ltd. and Bupa Investments Overseas Limited, are integral members of the globally renowned Bupa Group. Bupa, founded in 1947, serves over 50 million customers globally as of December 31, 2023. This international healthcare group operates without shareholders, reinvesting its profits to deliver enhanced healthcare services. With operations across the UK, Australia, Spain, Chile, Poland, and other regions, Bupa’s global presence provides them with unparalleled access to international health insurance expertise. This strong association makes them the only health insurance company in India with majority foreign ownership by a global healthcare group.

Industry Landscape and Competitive Position

India’s health insurance industry is categorized into three main types of providers: public insurers, private insurers, and SAHIs, with 21 private insurers and 7 IRDAI-recognized SAHIs as of August 31, 2024. The retail health insurance sector has emerged as a key driver in the industry due to its superior average premiums, renewal rates, and profitability metrics. Their continuous growth, product innovation, and strategic alliances position them to capitalize on these industry trends and enhance their market share further.

This comprehensive approach, combining innovation, strategic growth, and international expertise, underscores their commitment to being the health insurance provider of choice in India.

Objects of the Niva Bupa Health Insurance Company Limited IPO:

The company proposes to utilise the Net Proceeds towards the following objects: i. Augmentation of its capital base to strengthen solvency levels and ii. General corporate purposes Total number of shares issue:- i. Fresh issue is 108,108,108 shares, ii. Offer for sale is 189,189,189 shares.

Niva Bupa Health Insurance Company Limited IPO Details:

Open Date: Nov 07 2024
Close Date: Nov 11 2024
Total Shares: 297,297,297
Face Value: ₹ 10 Per Equity Share
Issue Size: 2,200.00 Cr.
Lot Size: 200 Shares
Issue Price: ₹ 70 - 74 Per Equity Share
Listing At: NSE,BSE
Listing Date: Nov 14 2024

Promoters And Management:

Chandrashekhar Bhaskar Bhave, Chairman and Independent Director of the Company, has been with them since December 2019. An alumnus of Jabalpur Engineering College, he has extensive experience in administrative services and securities regulation. He served as SEBI's senior executive director (1992-1996), chairman and managing director of NSDL (1996-2008), and chairman of SEBI (2008-2011), during which he also held leadership roles in international securities organizations and was a trustee of the IFRS Foundation in London. Krishnan Ramachandran, Managing Director and CEO of the Company since April 2020, holds a B.Tech in Electrical and Electronic Engineering from IIT Madras and a PGDM from IIM Calcutta. With over 24 years of experience in health insurance, healthcare, and life sciences, he previously served as CEO of Apollo Munich Health Insurance, consultant at Deloitte and Arthur Andersen, and COO of Apollo DKV Insurance in 2007. Pradeep Pant, an Independent Director of the Company since January 2015, holds a bachelor's degree in arts and economics from Delhi University and a master's in management from Jamnalal Bajaj Institute of Management Studies. He previously served as executive vice-president and president of Asia Pacific and EEMEA at Mondelēz International. He is also the founding president of Food Industry Asia and serves on the advisory board of SMU Lee Kong Chian School of Business.

Financials of Niva Bupa Health Insurance Company Limited IPO:

Particulars For 3 months ended June 30, 2024 FY 2023-24 FY 2022-23 FY 2021-22
Premium Earned (Net) 1,018.02 Cr. 3,811.24 Cr. 2,662.75 Cr. 1752.50 Cr.
Operating Profit 23.23 Cr. 188.02 Cr. 350.94 Cr. 45.74 Cr.
PAT (18.82) Cr. 81.85 Cr. 1.25 Cr. (196.52) Cr.

Comparison With Peers:

Companies Revenue Operating Profit PAT MCap P/E
NIVA Bupa (FY 2024) 3,811.24 Cr 188.02 Cr. 81.85 Cr.. 13380 Cr.  163
Star Health and Allied Insurance Company Ltd (TTM) 15,141 Cr. 1,145 Cr. 862 Cr. 28,283 Cr. 32.90
ICICI Lombard General Insurance Company Ltd (TTM) 22,315 Cr. 2,937 Cr. 2,225 Cr. 95,532 Cr. 43
The New India Assurance Company Ltd (TTM) 44,256 Cr. 1,710 Cr. 1,368 Cr. 31,823 Cr. 23.40

Recommendation on Niva Bupa Health Insurance Company Limited IPO:

Registrar of Niva Bupa Health Insurance Company Limited IPO:

  1. Kfin Technology Private Limited

Company Address:

Niva Bupa Health Insurance Company Limited C-98, 1st Floor Lajpat Nagar, Part 1 South Delhi, New Delhi-110024 Phone: +91 1246354900 Email: investor@nivabupa.com Website: https://www.nivabupa.com/

Discussion on Niva Bupa Health Insurance Company Limited IPO:

1 Comment

    Poor financial parameters. P/E of163 looks pathetic. Avoiding with out any hesitation.

Leave a Reply